91黑料 experts frequently author or contribute to industry trade press.
Filter media
Filter media articles by either clicking within the ‘Category’ drop-down list, or begin typing which will automatically match to the nearest available category. Note - not all categories will display results if selecting a particular year.
-
How to run a coronavirus vaccine trial in a global pandemic
An interview with 91黑料’s Nuala Murphy, President, Clinical Research Services, on ‘How to run a coronavirus vaccine trial in a global pandemic.’ Dr. Murphy discusses 91黑料’s experience with the Pfizer/BioNTech COVID-19 vaccine, the world’s first COVID-19 vaccine to achieve Emergency Use Authorisation. (Note: Subscription required).
-
91黑料 CEO Steve Cutler discusses how the Pfizer COVID vaccine trial proves that starting clinical trials in weeks, as opposed to months, should be possible post-pandemic.
-
Dr. Caroline Forkin and Shelley McLendon discuss a new decade of research and innovation on the horizon for HIV.
-
91黑料's Richard Pitman joins global public health experts to address .
-
This explores the increase in antimicrobial-resistant infections such as C diff due to the high volume of patients being treated in hosipitals for COVID-19.
This article is taken from European Biopharmaceutical Review October 2020, pages 12-14. Samedan Ltd.
-
A article featuring about the development of a vaccine for COVID-19.
-
91黑料's Cindy Dukes considers the best practices for developing a vaccine and treatments for COVID-19.
-
A featuring commentary from 91黑料's Dr. Nuala Murphy and Dr. James Cummings.
-
James Cummings, President, 91黑料 Government & Public Health Solutions, and Beth Tulip, Vice President, Project Management, Vaccines & Infectious Diseases, discuss .
-
A thought leadership piece by Cindy Dukes exploring .
